March 27–28 2017, Institut Curie, Paris

Scientific Program > Poster Presentations

Plasma sources and plasma equipment used for cancer treatment

  • Giovanni BUSCO, University of Orléans, France
    • Changes in oxygen level upon plasma treatments: consequences for RONS production?
  • Georg DAESCHLEIN, University of Greifswald, Germany
    • Suitability of cold plasma for treatment of actinic keratosis
  • Kristaq GAZELI, University of Paris-Saclay, France
    • Optimization of the chemical reactivity of cold atmospheric pressure microplasmas for application in cell treatments
  • David GRAVES, University of California Berkeley, United States of America
    • Advanced control of plasma medical devices
  • Kato SUSUMU, National Institute of Advanced Industrial Science and Technology, Japan
    • Sustaining mechanism of low energy atmospheric pressure plasma jets
  • Ali MESBAH, University of California Berkeley, United States of America
    • Model predictive control of atmospheric pressure plasma jets for effective dose delivery
  • Ekaterina SHERSHUNOVA, Russian Academy of Sciences, Russia
    • DBD-source with regulated average power for plasma medicine

Plasma-cancer interactions: experiments, modeling and simulation

  • Anthony CORDERO, University of Costa Rica, Costa Rica
    • In vitro evaluation of radiobiological response to x-rays, in breast cancer cells exposed to atmospheric pressure plasmas
  • Georg DAESCHLEIN, University of Greifswald, Germany
    • Combined plasma-chemotherapy is more effective than chemotherapy and plasma alone and saves adverse effects
  • Rico RUTKOWSKI, University of Greifswald, Germany
    • Head and neck cancer treatment with cold atmospheric plasma (CAP) – Hyperspectral imaging of therapeutic effects
  • Jonas VAN DER PAAL, University of Antwerp, Belgium
    • In search of the plasmaporation mechanism during plasma treatment of skin
  • Dayun YAN, George Washington University, United States of America
    • The strong H2O2 production by cancer cells during the direct cold atmospheric plasma treatment

Destruction of cancer cells by plasmas

  • James CURTIN, Dublin Institute of Technology, Ireland
    • Cold atmospheric plasma induces autophagic-like features and cell death in brain cancer cells
  • Natasa HOJNIK, Jozef Stefan Institute, Slovenia
    • The mechanisms behind the inhibitory effects of cold atmospheric plasma against cancer cells
  • Bruno HONNORAT, University Pierre and Marie Curie, France
    • Therapeutic effect of cold atmospheric plasma on oral cavity squamous cell carcinomas
  • Katarina KUCEROVA, Comenius University, Slovakia
    • Indirect treatment of cancer cells by air spark and corona discharge
  • Augusto STANCAMPIANO, University of Bologna, Italy
    • Atmospheric non-equilibrium plasma induces cell death, cell-cycle arrest, apoptosis and oxidative stress pathway regulation in cancer cells

Mechanisms of plasma selectivity towards cancer cells

  • Sander BEKESCHUS, INP Greifswald, Germany
    • Mitochondrial inhibtion syngergizes with plasma to elicit potent tumor cell killing
  • Emilio MARTINES, Consorzio RFX, Italy
    • Role of intracellular RONS and hypoxia-inducible factor in plasma-based cancer treatment
  • Warren ROWE, Jerome Canady Research Institute, United States of America
    • The effect of the Canady Helios cold plasma scalpel on the selective elimination of cancer
  • Steven VANUYTSEL, University of Antwerp, Belgium
    • Plasma cancer treatment coming of age: comparing in vitro selectivity of radio-, chemo-, and plasma therapy on glioblastoma multiforme

Plasma-liquid interaction / plasma chemistry in biological liquids / plasma activated media for cancer applications

  • Daniela BOEHM, Dublin Institute of Technology, Ireland
    • Cytotoxic mediators in PAW and PAL – Hydrogen peroxide and beyond
  • Marie BRETON, Institut Gustave Roussy, France
    • Study of the effect of a cold atmospheric plasma jet on the chemistry of membranes
  • Zhitong CHEN, George Washington University, United States of America
    • Novel micro-cold atmospheric plasma device for cancer treatment
  • Mohamed EL SHAER, University of Zagazig, Egypt
    • Effect of plasma activated mist on breast cancer cells
  • Bill GRAHAM, Queen's University Belfast, United Kingdom
    • A study of non-thermal plasma-liquid chemistry
  • Bruno HONNORAT, University Pierre and Marie Curie, France
    • Spectrophotometric and fluorimetric determination of reactive oxygen and nitrogen species produced by plasma-liquid interactions
  • Laurent INVERNIZZI, INU Champollion, France
    • Chemical and electrical characterization of a liquid target treated by a He/O2 plasma jet
  • Laurent INVERNIZZI, University of Paris-Saclay, France
    • Experimental study of plasma microjets as sources of reactive species for biomedical applications
  • Mounir LAROUSSI, Old Dominion University, United States of America
    • Comparative study on the viability of cancerous and non-cancerous epithelial cells treated by PAM
  • Nofel MERBAHI, University of Toulouse, France
    • Quantitative detection of radicals generated by plasma jet in culture medium
  • Hiromasa TANAKA, Nagoya University, Japan
    • Plasma activated medium and plasma activated ringer's lactate solution for cancer applications

Animal and clinical studies of cancer treatment by plasmas

  • Vandana MILLER, Drexel University, United States of America
    • Plasma created vaccine and vaccination strategy for immunotherapeutic control of deep tumors
Online user: 1 RSS Feed